- Home
- SGP vs PSEC Comparison
SGP vs PSEC Comparison
Compare SGP & PSEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SGP | PSEC |
|---|---|---|
| Founded | 2019 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 968.0M | 1.1B |
| IPO Year | 2026 | 2012 |
Fundamental Metrics
Financial Performance| Metric | SGP | PSEC |
|---|---|---|
| Price | $29.11 | $2.19 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 5 | 1 |
| Target Price | ★ $45.00 | $2.50 |
| AVG Volume (30 Days) | 86.8K | ★ 3.6M |
| Earning Date | 05-15-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 20.07% |
| EPS Growth | N/A | ★ 104.44 |
| EPS | N/A | ★ 0.06 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $37.26 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.06 | $2.11 |
| 52 Week High | $30.56 | $3.13 |
Technical Indicators
Market Signals| Indicator | SGP | PSEC |
|---|---|---|
| Relative Strength Index (RSI) | 55.73 | 46.29 |
| Support Level | $25.00 | $2.18 |
| Resistance Level | $29.90 | $2.32 |
| Average True Range (ATR) | 1.55 | 0.05 |
| MACD | -0.11 | -0.00 |
| Stochastic Oscillator | 55.78 | 25.00 |
Price Performance
Historical ComparisonAbout SGP SpyGlass Pharma Inc. Common Stock
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.
About PSEC Prospect Capital Corporation
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests mainly in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.